In addition, OX40 + plasmacytoid dendritic cells were enriched in the TME of HNSCC and generated specific CD8+ T cell responses to inhibit tumor growth (Poropatich et al., 2020). This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.